Codes / ICD10CM / T40.695D

T40.695D Adverse effect of other narcotics, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of other narcotics, subsequent encounter

Summary

This ICD-10-CM code represents a subsequent encounter for an adverse reaction resulting from the use of narcotics (opioids) not classified under more specific subcategories. It applies to encounters occurring after the initial treatment of the adverse effect, focusing on ongoing care or complications related to the initial event. The term "other" indicates the narcotics involved are not categorized elsewhere in the ICD-10-CM classification.

Causes

Adverse effects may result from medication errors, drug interactions, or individual sensitivity to narcotics. This can include reactions to prescribed or illicit substances where the specific type is known but not classified under more detailed subcategories. Overdose is not implied; the focus is on unintended harm from normal or subtherapeutic dosing.

Risk Factors

  • History of substance use or misuse.
  • Concurrent use of multiple medications or substances.
  • Cognitive impairments affecting medication management.
  • Lack of supervision or support for medication adherence.
  • Exposure to unknown or unregulated narcotic substances.

Symptoms

  • Respiratory depression (slow or shallow breathing).
  • Drowsiness or sedation.
  • Nausea, vomiting, or constipation.
  • Altered mental status (confusion, dizziness).
  • Hypotension or bradycardia.
  • Allergic reactions (rash, itching, swelling).

Diagnosis

Diagnosis involves evaluating the patient's history of narcotic exposure, clinical presentation, and ruling out other causes. Laboratory tests (e.g., toxicology screens) may confirm the presence of narcotics, while imaging or additional assessments address complications. Documentation must specify the adverse effect and its link to narcotic use.

Treatment Options

Treatment focuses on managing symptoms and preventing further harm. This may include discontinuing the offending substance, administering supportive care (e.g., respiratory support), and using antidotes if available. Ongoing monitoring and adjustment of care plans are essential for subsequent encounters.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Subsequent encounters often involve monitoring for resolution, recurrence, or long-term complications. Follow-up care may include medication adjustments, patient education, or referrals to specialists.

Complications

Potential complications include respiratory failure, cardiovascular instability, or persistent organ damage. Delayed recognition or treatment can worsen outcomes, emphasizing the need for careful monitoring during subsequent encounters.

Lifestyle & Prevention

Preventive measures include proper medication storage, adherence to prescribing guidelines, and patient education on risks. Avoiding illicit substances and disclosing all medications to healthcare providers can reduce adverse effect risks.

When to Seek Professional Help

Seek immediate care for severe symptoms (e.g., difficulty breathing, loss of consciousness) or if the adverse effect worsens. Follow up with a provider for persistent or new symptoms during subsequent encounters to adjust treatment as needed.

Tips for Medical Coders

Document the nature of the adverse effect, the specific narcotic involved (if known), and the encounter type (subsequent). Ensure clear linkage between the adverse effect and narcotic use. Use this code only for encounters occurring after the initial treatment phase.

Book a walkthrough

T40.695D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.